Development and validation of the mastocytosis activity score.

Frank SiebenhaarB SanderL H T HoA EllrichMarcus Maurer Karsten Weller

Published in: Allergy (2018)

The MAS is a disease-specific, valid and reliable patient-reported outcome measure for adult patients with cutaneous and indolent systemic mastocytosis. It may serve as a valuable tool to measure and monitor mastocytosis activity, both, in clinical trials and in routine care.

Keyphrases

patient reported outcomes
clinical trial
healthcare
palliative care
clinical practice
quality improvement
pain management
open label
study protocol